Michael Steinbaugh

Michael Steinbaugh has worked for a variety of organizations since 2004. Their first position was as a Research Intern at the Buck Institute for Research on Aging in 2004. Michael then worked as a Research Student at the Marine Biological Laboratory in 2008, followed by a Business Student at the University of Michigan Ross School of Business in 2009. In 2012, they became a Research Fellow at the Joslin Diabetes Center and Harvard Medical School. In 2017, they were a Research Associate at the Harvard T.H. Chan School of Public Health. In 2018, they were a Scientist II at Constellation Pharmaceuticals. Currently, they are a Director of Translational Science and Principal Scientist at Redona Therapeutics (formerly Twentyeight-Seven).

Michael Steinbaugh has a postdoc from Harvard Medical School in Genetics, a PhD from University of Michigan Medical School in Cellular and Molecular Biology, and a BS from University of California, Los Angeles in Microbiology, Immunology, Molecular Genetics with a Spanish Minor.